We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+4.18%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.05B
AUM Growth
+$125M
Cap. Flow
+$74.8M
Cap. Flow %
3.64%
Top 10 Hldgs %
22.74%
Holding
1,533
New
82
Increased
902
Reduced
480
Closed
69

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$30.9M
2
VZ icon
Verizon
VZ
+$26.8M
3
XOM icon
ExxonMobil
XOM
+$6.68M
4
SLB icon
SLB Ltd
SLB
+$3.54M
5
CVX icon
Chevron
CVX
+$3.5M

Top Sells

Rank Stock Value
1
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$15.9M
2
GILD icon
Gilead Sciences
GILD
+$5.42M
3
AMGN icon
Amgen
AMGN
+$3.44M
4
AAPL icon
Apple
AAPL
+$3.34M
5
CELG
Celgene Corp
CELG
+$2.83M

Sector Composition

Rank Sector Weight
1 Healthcare 26.04%
2 Communication Services 11.99%
3 Technology 11.14%
4 Energy 7.23%
5 Financials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
1
Amgen
AMGN
$201B
$68.4M 3.33%
449,840
-22,101
-5% -$3.44M
GILD icon
2
Gilead Sciences
GILD
$162B
$66.5M 3.24%
797,109
-61,062
-7% -$5.42M
ABBV icon
3
AbbVie
ABBV
$454B
$55.2M 2.69%
891,107
-40,236
-4% -$2.45M
T icon
4
AT&T
T
$160B
$55.2M 2.69%
1,690,348
+1,037,337
+159% +$30.9M
VZ icon
5
Verizon
VZ
$183B
$47.5M 2.31%
850,535
+516,538
+155% +$26.8M
CELG
6
DELISTED
Celgene Corp
CELG
$45.7M 2.23%
463,540
-27,394
-6% -$2.83M
AAPL icon
7
Apple
AAPL
$4.72T
$35M 1.7%
1,463,828
-134,464
-8% -$3.34M
BIIB icon
8
Biogen
BIIB
$29.6B
$31.7M 1.54%
131,050
-6,248
-5% -$1.65M
AMZN icon
9
Amazon
AMZN
$2.51T
$31.4M 1.53%
878,580
-78,400
-8% -$2.65M
XOM icon
10
ExxonMobil
XOM
$650B
$30.6M 1.49%
326,024
+75,514
+30% +$6.68M
MSFT icon
11
Microsoft
MSFT
$2.83T
$26.8M 1.3%
523,068
-44,718
-8% -$2.32M
META icon
12
Meta Platforms (Facebook)
META
$1.54T
$24M 1.17%
209,655
-11,860
-5% -$1.37M
JNJ icon
13
Johnson & Johnson
JNJ
$624B
$22M 1.07%
180,978
-16,594
-8% -$1.89M
GOOG icon
14
Alphabet (Google) Class C
GOOG
$3.88T
$18.3M 0.89%
529,200
-30,900
-6% -$1.11M
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$3.88T
$16.9M 0.82%
481,420
-22,080
-4% -$810K
REGN icon
16
Regeneron Pharmaceuticals
REGN
$68.3B
$16.7M 0.81%
47,872
-2,457
-5% -$946K
CVX icon
17
Chevron
CVX
$387B
$15.8M 0.77%
151,045
+34,765
+30% +$3.5M
ALXN
18
DELISTED
Alexion Pharmaceuticals
ALXN
$15.7M 0.76%
134,066
-7,447
-5% -$1.06M
PFE icon
19
Pfizer
PFE
$143B
$13.8M 0.67%
414,112
-36,275
-8% -$1.16M
INTC icon
20
Intel
INTC
$504B
$13.7M 0.67%
417,035
-30,402
-7% -$952K
VRTX icon
21
Vertex Pharmaceuticals
VRTX
$120B
$12.7M 0.62%
147,881
-6,508
-4% -$562K
ILMN icon
22
Illumina
ILMN
$29.8B
$12.4M 0.6%
90,637
-4,200
-4% -$597K
CMCSA icon
23
Comcast
CMCSA
$78.3B
$12.2M 0.6%
375,450
-32,188
-8% -$999K
SLB icon
24
SLB Ltd
SLB
$70.6B
$11.6M 0.56%
146,408
+46,145
+46% +$3.54M
MRK icon
25
Merck
MRK
$322B
$10.5M 0.51%
190,849
-15,433
-7% -$821K
1
2 3 4 5

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
APSPRSPT
Arizona Public Safety Personnel Retirement System (PSPRS) Trust Phoenix, Arizona $2.72B AUM 6.25% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Profund Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Profund Advisors held 1,533 positions worth $2.05B, up 6.5% from $1.93B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Profund Advisors deployed $74.8M of net new capital in Q2 2016, opening 82 new positions and adding to 902 existing holdings. Its largest new stake was Brocade Communications Systems, Inc. NEW: 79,318 shares worth $728K.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 29% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $5.42M trimmed.

  • Profund Advisors's largest Q2 2016 buy was Brocade Communications Systems, Inc. NEW: 79,318 shares worth $728K.
  • Profund Advisors added most to AT&T in Q2 2016, an estimated $30.9M increase.
  • Profund Advisors's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $5.42M.
  • Profund Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $15.9M.
  • Profund Advisors's ten largest holdings make up 23% of its $2.05B portfolio in Q2 2016.
  • Profund Advisors opened 82 new positions and closed 69 in Q2 2016.
  • Profund Advisors's portfolio value rose 6.5% quarter-over-quarter to $2.05B.

Based on Profund Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.